Clinical Trial Update: Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by Emory University is evaluating whether GLP-1 receptor agonist therapy can impact osteosarcopenia in older female adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Osteosarcopenia
• Sarcopenia
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist therapy (glucagon-like peptide-1 receptor agonist)

Snippet

Sponsor: Emory University | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: NOT_YET_RECRUITING